McDonald's Tests High Protein Menu As GLP-1 Weight-Loss Drug Users Surge

Core Insights - McDonald's is adapting its menu to cater to the growing number of Americans using GLP-1 weight-loss drugs, which influence portion sizes, snacking habits, and beverage choices [1][4] Group 1: Menu Adaptations - The company is testing high-protein menu items to appeal to customers on GLP-1 medications, as these consumers tend to prefer protein-rich meals [2] - Current high-protein options include Snack Wraps, Sausage Biscuit sandwiches, and McCrispy Strips, with a noted trend of reduced snacking and less consumption of sugary drinks among these customers [3] Group 2: Market Trends - Approximately 10% of the U.S. population is now using GLP-1 medications, leading to changes in consumer behavior that are prompting adjustments across the food industry [4] - Competitors like Conagra Brands and General Mills are also introducing smaller portion options labeled "GLP-1 friendly," while Shake Shack has launched a "Good Fit Menu" featuring high-protein and lettuce-wrapped burger options [5] Group 3: Financial Performance - McDonald's reported strong Q4 2025 results, with revenue of $6.83 billion and earnings per share of $3.05, surpassing analyst expectations [6] - The company's $5 meal deal significantly contributed to a 9% increase in U.S. same-store sales, appealing to budget-conscious consumers amid rising grocery costs [6][7]